Your browser doesn't support javascript.
loading
Towards in vitro models for reducing or replacing the use of animals in drug testing.
Stresser, David M; Kopec, Anna K; Hewitt, Philip; Hardwick, Rhiannon N; Van Vleet, Terry R; Mahalingaiah, Prathap Kumar S; O'Connell, Denice; Jenkins, Gary J; David, Rhiannon; Graham, Jessica; Lee, Donna; Ekert, Jason; Fullerton, Aaron; Villenave, Remi; Bajaj, Piyush; Gosset, James R; Ralston, Sherry L; Guha, Manti; Amador-Arjona, Alejandro; Khan, Kainat; Agarwal, Saket; Hasselgren, Catrin; Wang, Xiaoting; Adams, Khary; Kaushik, Gaurav; Raczynski, Arkadiusz; Homan, Kimberly A.
Afiliación
  • Stresser DM; Quantitative, Translational & ADME Sciences, AbbVie, North Chicago, IL, USA. david.stresser@abbvie.com.
  • Kopec AK; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), . david.stresser@abbvie.com.
  • Hewitt P; IQ Microphysiological Systems Affiliate (IQ-), . david.stresser@abbvie.com.
  • Hardwick RN; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Van Vleet TR; IQ Microphysiological Systems Affiliate (IQ-).
  • Mahalingaiah PKS; Drug Safety Research & Development, Pfizer, Inc., Groton, CT, USA.
  • O'Connell D; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Jenkins GJ; IQ Microphysiological Systems Affiliate (IQ-).
  • David R; Chemical and Preclinical Safety, Merck KGaA, Darmstadt, Germany.
  • Graham J; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Lee D; IQ Microphysiological Systems Affiliate (IQ-).
  • Ekert J; Discovery Toxicology, Pharmaceutical Candidate Optimization, Bristol Myers Squibb, San Diego, CA, USA.
  • Fullerton A; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Villenave R; IQ Microphysiological Systems Affiliate (IQ-).
  • Bajaj P; Investigative Toxicology and Pathology, AbbVie, North Chicago, IL, USA.
  • Gosset JR; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Ralston SL; IQ Microphysiological Systems Affiliate (IQ-).
  • Guha M; Investigative Toxicology and Pathology, AbbVie, North Chicago, IL, USA.
  • Amador-Arjona A; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Khan K; Global Animal Welfare, AbbVie, North Chicago, IL, USA.
  • Agarwal S; IQ 3Rs (Replacement, Reduction, Refinement) Translational and Predictive Sciences Leadership Group.
  • Hasselgren C; Quantitative, Translational & ADME Sciences, AbbVie, North Chicago, IL, USA.
  • Wang X; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Adams K; IQ Translational and ADME Sciences Leadership Group (TALG).
  • Kaushik G; International Consortium for Innovation and Quality in Pharmaceutical Development (IQ).
  • Raczynski A; IQ Microphysiological Systems Affiliate (IQ-).
  • Homan KA; Clinical Pharmacology & Safety Sciences, AstraZeneca, Cambridge, UK.
Nat Biomed Eng ; 8(8): 930-935, 2024 Aug.
Article en En | MEDLINE | ID: mdl-38151640
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alternativas a las Pruebas en Animales Límite: Animals / Humans Idioma: En Revista: Nat Biomed Eng Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Alternativas a las Pruebas en Animales Límite: Animals / Humans Idioma: En Revista: Nat Biomed Eng Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido